Bifogade filer
PDF
Kurs
-4,00%
Likviditet
0,07 MSEK
Kalender
| Est. tid* | ||
| 2026-04-21 | 11:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-26 | 08:00 | Bokslutskommuniké 2025 |
| 2026-02-09 | - | Extra Bolagsstämma 2026 |
| 2025-11-27 | - | Kvartalsrapport 2025-Q3 |
| 2025-11-21 | - | Extra Bolagsstämma 2025 |
| 2025-08-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 |
| 2025-05-09 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2025-05-08 | - | Årsstämma |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2025-02-20 | - | Extra Bolagsstämma 2024 |
| 2024-12-05 | - | Split POLAR 300:1 |
| 2024-11-29 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-31 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-29 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2024-05-28 | - | Årsstämma |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2023-11-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-09-08 | - | Extra Bolagsstämma 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-17 | - | Årsstämma |
| 2023-05-05 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2023-03-13 | - | Extra Bolagsstämma 2022 |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2022-11-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2021-05-05 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2020-06-30 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2020-02-14 | - | Extra Bolagsstämma 2020 |
| 2019-10-23 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-24 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | Split POLAR 16:1 |
| 2019-04-26 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-19 | - | Årsstämma |
| 2019-02-04 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2019-02-01 | - | Bokslutskommuniké 2018 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
The med-tech company PolarCool AB (publ.) is strengthening its presence in European ice hockey by signing its first agreement within French ice hockey. Rouen Hockey Elite 76 becomes the first French ice hockey club to integrate PolarCap® into its concussion management routines.
Entry into France's top division, Ligue Magnus, marks PolarCool's expansion into another European market. The company has already established a strong presence in several leading ice hockey leagues, including those in Sweden, Finland, Germany, Austria, the United Kingdom, Switzerland, the Czech Republic, and Slovakia.
PolarCool's CEO, Erik Andersson, comments:
-I am very pleased that we have signed our first agreement in French professional ice hockey. Rouen Hockey Elite 76 is a well-established club and will serve as an important reference for PolarCap® in French ice hockey. We look forward to the collaboration and hope that more clubs in Ligue Magnus will follow their example.
The agreement with Rouen Hockey Elite 76 represents a strategic value for PolarCool and marks a breakthrough in the French ice hockey market. The club will use PolarCap® for the remainder of the season during an initial evaluation period, with the possibility of continuing into a two-year commercial agreement following the evaluation.
For more information
Erik Andersson - CEO PolarCool AB (publ.)
+46 - 73 860 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ.)
PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.